{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360285707257585408.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jhep.2015.03.020"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827815002032?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827815002032?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"25817219"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Characterization of novel entecavir resistance mutations"}],"description":[{"notation":[{"@value":"Entecavir (ETV) is approved for the treatment of chronic hepatitis B virus (HBV) infections, but the virus can acquire resistance to the drug. This requires lamivudine resistance mutations (LAMr) and at least one additional mutation. Here, we characterized two novel mutations, rtI163V and rtA186T, associated with viral breakthrough (VBT) in an ETV-refractory patient.HBV from an ETV-refractory patient was sequenced, and newly identified mutations were inserted into a replication-competent clone by mutagenesis. Clones were analyzed for replication efficacy and susceptibility to ETV in vitro. Chimeric mice with human hepatocytes were inoculated with the patient's serum at VBT, and monitored for viral mutation pattern using a next-generation sequencing approach.RtI163V and rtA186T mutations were detected together with LAMr (rtL180M and rtM204V) at VBT. RtA186T plus LAMr reduced susceptibility to ETV more than 111.1-fold compared with the wild-type clone, while rtI163V plus LAMr resulted in a 20.4-fold reduction. RtA186T significantly reduced viral replication efficacy, while the rtI163V mutation rescued it. Interestingly, the viral mutation pattern in the chimeric mice indicated dominant (or selective) proliferation of a clone containing rtI163V and rtA186T mutations plus LAMr under ETV treatment. Three-dimensional docking simulation indicated that rtA186T reduced the binding affinity of the HBV polymerase to ETV.VBT in this ETV-refractory patient is attributable to the novel ETV resistance mutations rtI163V and rtA186T. RtA186T was apparently responsible for ETV resistance but the selection of a clone with the double mutation plus LAMr suggests that rtI163V is required to sustain viral fitness."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420845751158774144","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10597587"},{"@type":"NRID","@value":"1000010597587"},{"@type":"NRID","@value":"9000283344640"},{"@type":"NRID","@value":"9000018799230"},{"@type":"NRID","@value":"9000257810080"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/sanaehayashi66"}],"foaf:name":[{"@value":"Sanae Hayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585280","@type":"Researcher","foaf:name":[{"@value":"Shuko Murakami"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585414","@type":"Researcher","foaf:name":[{"@value":"Katsumi Omagari"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585415","@type":"Researcher","foaf:name":[{"@value":"Takeshi Matsui"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585412","@type":"Researcher","foaf:name":[{"@value":"Etsuko Iio"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326233159424","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50723201"},{"@type":"NRID","@value":"1000050723201"},{"@type":"NRID","@value":"9000410904978"},{"@type":"NRID","@value":"9000414380334"},{"@type":"NRID","@value":"9000410904856"},{"@type":"NRID","@value":"9000020678943"},{"@type":"NRID","@value":"9000326653825"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/misogawa"}],"foaf:name":[{"@value":"Masanori Isogawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585409","@type":"Researcher","foaf:name":[{"@value":"Tsunamasa Watanabe"}]},{"@id":"https://cir.nii.ac.jp/crid/1380285707257585411","@type":"Researcher","foaf:name":[{"@value":"Yoshiyasu Karino"}]},{"@id":"https://cir.nii.ac.jp/crid/1420564276190463488","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"90336694"},{"@type":"NRID","@value":"1000090336694"},{"@type":"ORCID","@value":"0000-0002-2473-6966"},{"@type":"NRID","@value":"9000003770453"},{"@type":"NRID","@value":"9000238231944"},{"@type":"NRID","@value":"9000347341653"},{"@type":"NRID","@value":"9000016417865"},{"@type":"NRID","@value":"9000018528365"},{"@type":"NRID","@value":"9000283478036"},{"@type":"NRID","@value":"9000413693585"},{"@type":"NRID","@value":"9000248223609"},{"@type":"NRID","@value":"9000024824540"},{"@type":"NRID","@value":"9000409619114"},{"@type":"NRID","@value":"9000014172694"},{"@type":"NRID","@value":"9000248229432"},{"@type":"NRID","@value":"9000002003744"},{"@type":"NRID","@value":"9000002135075"},{"@type":"NRID","@value":"9000386384751"},{"@type":"NRID","@value":"9000380482416"},{"@type":"NRID","@value":"9000018971579"},{"@type":"NRID","@value":"9000329896066"},{"@type":"NRID","@value":"9000409578665"},{"@type":"NRID","@value":"9000390885432"},{"@type":"NRID","@value":"9000396168015"},{"@type":"NRID","@value":"9000018394307"},{"@type":"NRID","@value":"9000403298965"},{"@type":"NRID","@value":"9000248228892"},{"@type":"NRID","@value":"9000409341437"},{"@type":"NRID","@value":"9000248229700"},{"@type":"NRID","@value":"9000404344556"},{"@type":"NRID","@value":"9000377381982"},{"@type":"NRID","@value":"9000398628342"},{"@type":"NRID","@value":"9000018971558"},{"@type":"NRID","@value":"9000248229052"},{"@type":"NRID","@value":"9000248229111"},{"@type":"NRID","@value":"9000263063578"},{"@type":"NRID","@value":"9000411812617"},{"@type":"NRID","@value":"9000001940546"},{"@type":"NRID","@value":"9000016417617"},{"@type":"NRID","@value":"9000017178030"},{"@type":"NRID","@value":"9000248228516"},{"@type":"NRID","@value":"9000024726744"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/Yasuhito_Tanaka"}],"foaf:name":[{"@value":"Yasuhito Tanaka"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01688278"}],"prism:publicationName":[{"@value":"Journal of Hepatology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2015-09","prism:volume":"63","prism:number":"3","prism:startingPage":"546","prism:endingPage":"553"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0168827815002032?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0168827815002032?httpAccept=text/plain"}],"createdAt":"2015-05-09","modifiedAt":"2022-11-16","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Models,%20Molecular","dc:title":"Models, Molecular"},{"@id":"https://cir.nii.ac.jp/all?q=Guanine","dc:title":"Guanine"},{"@id":"https://cir.nii.ac.jp/all?q=RNA-Directed%20DNA%20Polymerase","dc:title":"RNA-Directed DNA Polymerase"},{"@id":"https://cir.nii.ac.jp/all?q=Antiviral%20Agents","dc:title":"Antiviral Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Mice","dc:title":"Mice"},{"@id":"https://cir.nii.ac.jp/all?q=Hepatitis%20B,%20Chronic","dc:title":"Hepatitis B, Chronic"},{"@id":"https://cir.nii.ac.jp/all?q=Drug%20Resistance,%20Viral","dc:title":"Drug Resistance, Viral"},{"@id":"https://cir.nii.ac.jp/all?q=Mutation","dc:title":"Mutation"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040282257222496128","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25293176"},{"@type":"JGN","@value":"JP25293176"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25293176/"}],"notation":[{"@language":"ja","@value":"iPS細胞を活用したヒトキメラマウス肝炎発症モデルの開発とその臨床応用"},{"@language":"en","@value":"Development and clinical evaluation of hepatitis onset model of chimeric mice with iPS-derived human hepatocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257279700096","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26461015"},{"@type":"JGN","@value":"JP26461015"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26461015/"}],"notation":[{"@language":"ja","@value":"自然免疫活性化によるB型肝炎ウイルス特異的T細胞応答の誘導"},{"@language":"en","@value":"Induction of hepatitis B virus specific T cell responses by activating innate immune response"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050297128924508672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing"}]},{"@id":"https://cir.nii.ac.jp/crid/1050585658872364544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002220988374656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232002369024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144955306880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619707247488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619825320320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Presto(protein engineering simulator): A vectorized molecular mechanics program for biopolymers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620876472704","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621420478336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567180081041536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567180081466752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Resistance mutations of hepatitis B virus in entecavir‐refractory patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185916732416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568466580205568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems."}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092698125312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"7-Deaza-7-fluoro modification confers on 4′-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093500552064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094717272320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Near Completely Humanized Liver in Mice Shows Human-Type Metabolic Responses to Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658414012544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568722701568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571066480128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571546027008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens†‡"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814738709120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869856039344000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045436302080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518853652224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D †"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694368238873088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994154033408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In Vitro Activity of 2,4-Diamino-6-[2-(Phosphonomethoxy)Ethoxy]-Pyrimidine against Multidrug-Resistant Hepatitis B Virus Mutants"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994536370560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cellular and virological mechanisms of HBV drug resistance"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994827072896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470586245632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinical Assessment and Molecular Docking Simulation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471231080448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of Hepatitis B Virus Polymerase by Entecavir"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419163194112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Successful treatment of an entecavir‐resistant hepatitis B virus variant"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419452488448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419885318016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of simple potential functions for simulating liquid water"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420738448000","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir†"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895162591872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B Virus DNA-negative Dane Particles Lack Core Protein but Contain a 22-kDa Precore Protein without C-terminal Arginine-rich Domain"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895511039104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Similarities among receptor pockets and among compounds: Analysis and application to in silico ligand screening"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370913660928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and Lobucavir"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319693441408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Entecavir resistance is rare in nucleoside naïve patients with hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319965545600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320988991744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Navigating the Maze of Hepatitis B Treatments"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794295554176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine"}]},{"@id":"https://cir.nii.ac.jp/crid/1371132819266453121","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication"}]},{"@id":"https://cir.nii.ac.jp/crid/1371132819266453126","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A method to enhance the hit ratio by a combination of structure-based drug screening and ligand-based screening"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204795265920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"新規核酸アナログ4'-C-cyano-2-amino-2'-deoxyadenosine，4'-C-cyano-2'-deoxyguanosineは薬剤耐性B型肝炎ウイルス変異株に対して有効である"},{"@language":"en","@value":"Novel 4'-modified nucleoside analogs exert antiviral replication against hepatitis B virus with drug resistance mutations"},{"@language":"ja-Kana","@value":"シンキ カクサン アナログ 4'-C-cyano-2-amino-2'-deoxyadenosine,4'-C-cyano-2'-deoxyguanosine ワ ヤクザイ タイセイ Bガタ カンエンウイルス ヘンイカブ ニ タイシテ ユウコウ デ アル"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jhep.2015.03.020"},{"@type":"KAKEN","@value":"PRODUCT-20630043"},{"@type":"KAKEN","@value":"PRODUCT-20261018"},{"@type":"OPENAIRE","@value":"doi_dedup___::8fefb02894a64fcbf6bfcd798026dfa6"},{"@type":"CROSSREF","@value":"10.4254/wjh.v9.i9.477_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1016/j.antiviral.2019.104537_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1038/s41598-022-05882-9_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2019.01.026_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1002/hep.30111_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1002/hep4.1022_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1128/aac.00183-17_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.2957/kanzo.57.299_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1016/j.antiviral.2020.104744_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1097/hc9.0000000000000047_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-19602-9_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1007/s00535-023-02070-y_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1038/s41598-024-66505-z_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-59775-w_references_DOI_R43HuPWjaUAFqltYHUZTdkBd2yE"}]}